Nrf2-targeted genes involved in foreign biological metabolism can accelerate the metabolic inactivation of antitumor drugs; genes involved in drug transport can effectively reduce the intracellular drug concentration, and genes involved in thiosulfur synthesis can increase the drug tolerance of tumor cells. Here, NFE2L2 is linked to neoplasm.